Pantoprazole sodium for injection is indicated for short-term treatment of adult patients with gastroesophageal reflux disease, a history of erosive esophagitis and pathological hypersecretion.
The formulation is approved to treat seven indications, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis and plaque psoriasis.
The proposed Abatacept biosimilar is a dual biologic intended to suppress neuroinflammation via multiple immunomodulatory pathways, for the treatment of neurodegenerative conditions.
Generic Aubagio treats relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, in adults.